Data / Form D filings / 76Bio, Inc.
76Bio, Inc.: Form D filings
76Bio, Inc., a biotechnology company in Boston, MA, filed 3 Form D notices with the SEC between 2022 and 2023. The latest, on February 14, 2023, reports $12.2 million sold of a $12.2 million offering to 32 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 40 Guest Street, Boston, MA, 01235
- Phone
- (212) 871-7920
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1903465
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 14, 2023 | Amendment | $12,220,600 | $12,220,600 | 32 | Feb 6, 2023 | sec.gov | |
| Feb 13, 2023 | New notice | $12,220,600 | $12,220,600 | 32 | Feb 6, 2023 | sec.gov | |
| Jan 10, 2022 | New notice | $10,005,244 | $10,005,244 | 44 | Dec 22, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher M. Wilfong | Executive Officer, Director, Promoter | |
| David M. Tanen | Director, Promoter | |
| Angela M. Koehler | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Feb 13, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what 76Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.